Titre :
  • Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer-8-year results of the breast international group 02-98 phase III trial
Auteur : Oakman, Catherine ; Di Leo, Angelo ; Francis, Prudence ; Crown, John ; Quinaux, Emmanuel ; Buyse, Marc ; Azambuja, Evandro ; Punzalan, L. ; Piccart-Gebhart, Martine ; Vila, Mireia Margeli ; Andersson, Michael M. ; Nordenskjöld, B ; Jakesz, Raimund ; Thürlimann, Beat ; Gutiérrez, Jorge Martos J. ; Harvey, Vernon ; Dell'Orto, Patrizia ; Viale, Giuseppe ; Larsimont, Denis ; Steinberg, I. I. ; Gelber, Richard
Informations sur la publication : Annals of oncology, 24, 5, mds627, (page 1203-1211)
Statut de publication : Publié, 2013-05
Sujet CREF : Hématologie
Cancérologie
Mots-clés : Adjuvant
Breast cancer
Chemotherapy
Docetaxel
Doxorubicin
Sequential
Mots-clés MeSH : Adolescent
Adult
Aged
Antineoplastic Agents -- administration & dosage -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- therapeutic use
Breast Neoplasms -- drug therapy -- mortality
Cyclophosphamide -- administration & dosage -- therapeutic use
Disease-Free Survival
Doxorubicin -- administration & dosage -- therapeutic use
Drug Administration Schedule
Female
Fluorouracil -- administration & dosage -- therapeutic use
Humans
Lymphatic Metastasis
Methotrexate -- administration & dosage -- therapeutic use
Middle Aged
Taxoids -- administration & dosage -- therapeutic use
Young Adult
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mds627
info:pii/mds627
info:pmid/23293111